CRL
Charles River Laboratories International, Inc.Company with tickers: CRL
CIK
1100682
CUSIP
159864107
Shares Outstanding
48,167,730
13F Activity (30d)
424 filings
422 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $995,830,000 | USD | 2026-03-28 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | $119,897,000 | USD | 2026-03-28 | 10-Q | 2026-05-07 |
| Net Income | $-14,843,000 | USD | 2026-03-28 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.30 | USD/shares | 2026-03-28 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.30 | USD/shares | 2026-03-28 | 10-Q | 2026-05-07 |